Cemtrex Inc. (NASDAQ:CETX) recently announced in an 8-K filing that it has regained compliance with the minimum stockholder’s equity requirements for continued listing on The Nasdaq Capital Market.

Psyence Biomedical (PBM) announced that it has received notice from the Nasdaq Hearings panel that the Company has regained compliance with all applicable Nasdaq continued listing requirements.

(Nasdaq: PBM) (“Psyence Biomed” or the ... has regained compliance with all applicable Nasdaq continued listing requirements. As previously announced, Psyence Biomed requested to be ...

OneMedNet (ONMD) regained compliance with Nasdaq Listing Rule 5250(c)(1) based on the filing of its periodic reports on Form 10-Q for the fiscal quarters ended March 31, June 30 and September 30 ...

Shares of N2Off Inc. (NITO) rose in morning trade on Wednesday after the company received a 180-day extension from the Nasdaq ...

The Nasdaq Composite increased 243.30 points or 1.2% to close at 19,864.98, also booking back-to-back gains. The tech-heavy ...

In what will likely mark the final outcome, the U.S. Court of Appeals for the Fifth Circuit, sitting en banc, struck down the ...

Nasdaq is proposing a rule change to modify the initial listing requirements related to liquidity. More specifically, Nasdaq is proposing to change Listing Rules 5405 and 5505 to require that a ...

Nasdaq officials have reviewed the decision, said Emily Pan, a spokeswoman for the exchange. “We maintain that the rule simplified and standardized disclosure requirements to the benefit of both ...

The press release also contains forward-looking statements regarding IceCure Medical (TASE:PMCN)'s expectations for continued listing and compliance with Nasdaq requirements. However, these ...

BOSTON, Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced ...